Bleomycin genotoxicity and amifostine (WR-2721) cell protection in normal leukocytes vs. K562 tumoral cells.
Buschini A
Biochem Pharmacol. 63(5):967-75.
Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts
Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation.
Cilloni D
Blood. 96(10):3637-43.
Large-scale feasibility of gene transduction into human CD34+ cell-derived dendritic cells by adenoviral/polycation complex.
Di Nicola M
Br J Haematol. 111(1):344-50.
Amifostine (WR-2721) selective protection against melphalan genotoxicity.
Buschini A
Leukemia. 14(9):1642-51.
T-lymphocyte function after retroviral-mediated thymidine kinase gene transfer and G418 selection.
Di Ianni M
Cancer Gene Ther. 7(6):920-6.
Transforming growth factor beta3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis.
Fogli M
Exp Hematol. 28(7):775-83.
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemias.
Bonati A
Cancer Res. 60(3):728-32.
Peripheral blood progenitor cell mobilization in healthy donors receiving recombinant human granulocyte colony-stimulating factor.
Carlo-Stella C
Exp Hematol. 28(2):216-24.
Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT
Cancer Res. 59(19):5047-53.